Actively Recruiting
Change-a Multi-center Chronic Thromboembolic Pulmonary Hypertension （CTEPH） Database in China
Led by China-Japan Friendship Hospital · Updated on 2024-01-23
1500
Participants Needed
1
Research Sites
639 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Change Database is a prospective, observational multi-center disease registry, which will collect data on patients with chronic thromboembolic pulmonary hypertension (CTEPH) in China. It aims to illustrate the epidemiology, management and long-term outcomes of CTEPH.
CONDITIONS
Official Title
Change-a Multi-center Chronic Thromboembolic Pulmonary Hypertension （CTEPH） Database in China
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH)
- Willingness to provide informed consent
- Mean pulmonary artery pressure (mPAP) of 20 mmHg or higher
- Pulmonary vascular resistance (PVR) of 3 Wood units or higher
- Pulmonary arterial wedge pressure (PAWP) of 15 mmHg or lower
- Radiographic evidence of organized pulmonary artery thrombi after 3 months of effective anticoagulation
You will not qualify if you...
- Pulmonary hypertension primarily caused by conditions other than CTEPH
- Participation in a therapeutic clinical trial involving an unknown drug
- Withdrawal or lack of informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
China-Japan Frendship hospital
Beijing, China, 100029
Actively Recruiting
Research Team
Z
Zhenguo Zhai, Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here